Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer

Molecular Biology Reports

Volumn 40, Issue 5, 2013, Pages 3493-3502

  Forma, Ewa ^a   Brzeziańska, Ewa ^b   Krześlak, Anna ^a   Chwatko, Grazyna ^a   Jóźwiak, Paweł ^a   Szymczyk, Agnieszka ^a   Smolarz, Beata ^a   Romanowicz Makowska, Hanna ^a   Różański, Waldemar ^b   Bryś, Magdalena ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Breast cancer; Genetic variation; Polymorphism; Topoisomerase II binding protein 1

Indexed keywords

BINDING PROTEIN; CYTIDINE; MESSENGER RNA; THYMIDINE; TOPOISOMERASE II BETA BINDING PROTEIN 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TOPBP1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC CORRELATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOPBP1 GENE; AGED; BREAST TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK; RISK FACTOR; VERY ELDERLY;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CARRIER PROTEINS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84878381794     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2424-z     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33:315-318
3. Peng S, Lü B, Ruan W, Zhu Y, Sheng H, Lai M (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127:309-324
4. Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A (2012) Breast cancer genome-wide association studies: there is strength in numbers. Oncogene 31:2121-2128. doi: 10.1038/onc.2011.408
5. Forma E, Brys M, Krajewska W (2011) TopBP1 in DNA damage response. In: Kruman I (ed) DNA repair/book 4. INTECH Open Access Publisher, Rijeka, pp 281-304
6. Jeon Y, Ko E, Lee KY, Ko MJ, Park SY, Kang J, Jeon CH, Lee H, Hwang DS (2011) TopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cells. J Biol Chem 286:5414-5422
7. Xu Y, Leffak M (2010) ATRIP from TopBP1 to ATR - in vitro activation of a DNA damage checkpoint. Proc Natl Acad Sci USA 107:13561-13562
8. Glover JNM (2006) Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain. Fam Cancer 5:89-93
9. Sokka M, Parkkinen S, Pospiech H, Syväoja JE (2010) Function of TopBP1 in genome stability. Subcell Biochem 50:119-141
10. Rodriguez MC, Songyang Z (2008) BRCT domains: phosphopeptide binding and signaling modules. Front Biosci 13:5905-5915
11. Fleming ID, Cooper JS, Henson DE, Hutter R, Kennedy B, Murphy G, O'Sullivan B, Yarbo J, Sobin L (1997) AJCC cancer staging manual, 5th edn. Lippincott-Raven, Philadelphia
12. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 19:403-410
13. Yokoyama A, Kato H, Yokoyama T, Tsujinaka T, Muto M, Omori T, Haneda T, Kumagai Y, Igaki H, Yokoyama M, Watanabe H, Fukuda H, Yoshimizu H (2002) Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma. Carcinogenesis 23:1851-1859
14. Morris JS, Nixon C, Bruck A, Nasir L, Morgan IM, Philbey AW (2008) Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53. Vet J 175:218-226
15. Morris JS, Nixon C, King OJA, Morgan IM, Philbey AW (2009) Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERα and p53. Vet J 179:422-429
16. Liu K, Bellam N, Lin HY, Wang B, Stockard CR, Grizzle WE, Lin WC (2009) Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer. Mol Cell Biol 29:2673-2693
17. Forma E, KrzeÅlak A, Bernaciak M, Romanowicz-Makowska H, BryÅ M (2012) Expression of TopBP1 in hereditary breast cancer. Mol Biol Rep 39:7795-7804
18. Chatterjee S, Pal JK (2009) Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell 101:251-262
19. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
20. Liu X, Fortin K, Mourelatos Z (2008) MicroRNAs: biogenesis and molecular functions. Brain Pathol 18:113-121
21. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN, Deltas C (2012) A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS One 7:e31021
22. Karppinen SM, Erkko H, Reini K, Pospiech H, Heikkinen K, Rapakko K, Syväoja JE, Winqvist R (2006) Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer. Eur J Cancer 42:2647-2652
23. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96:29-37
24. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27:1377-1385
25. Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 7:R987-R997
26. Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J (2006) XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66:2860-2868
27. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM (2005) Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:336-342
28. Shore RE, Zeleniuch-Jacquotte A, Currie D, Mohrenweiser H, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I (2008) Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 122:2101-2105
29. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-619
30. Brooks PJ, Theruvathu JA (2005) DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 35:187-193